FDA Study Shows Statins Don’t Increase Risk of ALS

Give millions of people a drug, and some of them are going to come down with rare diseases. Of course, if you follow millions of people who aren’t taking any drugs, some of them are going to come down with rare diseases, too. So it can be tough to tell whether a drug slightly increases the risk of trouble.

That’s been an issue for statins, the wildly popular class of cholesterol drugs that includes Pfizer’s Lipitor, Merck’s Zocor and AstraZeneca’s Crestor. Sporadic reports had come in of patients developing ALS, also known as Lou Gehrig’s disease, while taking statins. As we noted last year, at least one prominent researcher thought there might be a connection there.

Indeed, the reports were substantive enough to compel the FDA to look into the issue.

FDA is a liar, i think they has been corrupted and this is a case of bribe giving by Pfizer ,Merck and other manufacturers of interest.
My father died of pulmonary fibrosis and then ALS/MND-like syndrom after 9 years on Simvastatin.
I suggest statins to name not remedy but as poisons.

7:11 am October 2, 2008

Allen wrote :

Trial data can and is interpreted differently by those reading or writing the trials. A lot of data that does not seem to fit a criteria has been found to be omitted or altered to suit the trials end goals or to favour the payee of the trial. How many trials were there to actually look for ALS?
The above remark is not a conspiracy theory, it is what has been reported and half hidden so many times, trials without placebos, selective candidates etc lead to a great deal of artificial end results.

I know statins are a major danger to health for a vast number of humans, I am one of them and this stuff really is poison.

3:22 pm September 30, 2008

scientist wrote :

the absence of a link in registration clinical trial data must not be confused as being the equivalent of a lack of such a link in the real world. these trials have different entry criteria and concomittant illness exposure risks than patients exposed in the real world.